Literature DB >> 20552039

Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.

Javier Rangel-Moreno1, Damian Carragher, Troy D Randall.   

Abstract

Secondary lymphoid organs are strategically placed to recruit locally activated antigen presenting cells (APCs) as well as naïve, recirculating T and B cells. The structure of secondary lymphoid organs - separated B and T zones, populations of specialized stromal cells, high endothelial venules and lymphatic vessles - has also evolved to maximize encounters between APCs and lymphocytes and to facilitate the expansion and differentiation of antigen-stimulated T and B cells. Many of the general mechanisms that govern the development and organization of secondary lymphoid organs have been identified over the last decade. However, the specific cellular and molecular interactions involved in the development and organization of each secondary lymphoid organ are slightly different and probably reflect the cell types available at that time and location. Here we review the mechanisms involved in the development, organization and function of local lymphoid tissues in the respiratory tract, including Nasal Associated Lymphoid Tissue (NALT) and inducible Bronchus Associated Lymphoid Tissue (iBALT).

Year:  2007        PMID: 20552039      PMCID: PMC2884405     

Source DB:  PubMed          Journal:  Inmunologia        ISSN: 0213-9626


  193 in total

Review 1.  Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines.

Authors:  P Hjelmström
Journal:  J Leukoc Biol       Date:  2001-03       Impact factor: 4.962

2.  A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria.

Authors:  A J Macpherson; D Gatto; E Sainsbury; G R Harriman; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  2000-06-23       Impact factor: 47.728

3.  Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins.

Authors:  P J Giannasca; J A Boden; T P Monath
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children.

Authors:  J C King; R Lagos; D I Bernstein; P A Piedra; K Kotloff; M Bryant; I Cho; R B Belshe
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

5.  HIV mucosal vaccine: nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1- and Th2-deficient conditions.

Authors:  T Hiroi; H Goto; K Someya; M Yanagita; M Honda; N Yamanaka; H Kiyono
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

6.  Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry.

Authors:  C H Bosken; J Hards; K Gatter; J C Hogg
Journal:  Am Rev Respir Dis       Date:  1992-04

Review 7.  Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.

Authors:  Lisa M Ebert; Patrick Schaerli; Bernhard Moser
Journal:  Mol Immunol       Date:  2004-11-23       Impact factor: 4.407

8.  Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.

Authors:  P L Heritage; B J Underdown; A L Arsenault; D P Snider; M R McDermott
Journal:  Am J Respir Crit Care Med       Date:  1997-10       Impact factor: 21.405

9.  CD4+CD3- cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5.

Authors:  D Finke; H Acha-Orbea; A Mattis; M Lipp; J Kraehenbuhl
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

10.  Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.

Authors:  R Endres; M B Alimzhanov; T Plitz; A Fütterer; M H Kosco-Vilbois; S A Nedospasov; K Rajewsky; K Pfeffer
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  6 in total

1.  The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cells.

Authors:  Andrea Rückle; Emanuel Haasbach; Ilkka Julkunen; Oliver Planz; Christina Ehrhardt; Stephan Ludwig
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

Review 2.  Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.

Authors:  Ekaterina P Koroleva; Yang-Xin Fu; Alexei V Tumanov
Journal:  Cytokine       Date:  2016-09-09       Impact factor: 3.861

3.  Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia.

Authors:  Damiana Chiavolini; Javier Rangel-Moreno; Gretchen Berg; Kate Christian; Laura Oliveira-Nascimento; Susan Weir; Joseph Alroy; Troy D Randall; Lee M Wetzler
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

Review 4.  The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation.

Authors:  Koshika Yadava; Paul Bollyky; Melissa A Lawson
Journal:  Immunology       Date:  2016-08-16       Impact factor: 7.397

5.  Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction.

Authors:  Saba Nayar; Elena Pontarini; Joana Campos; Onorina Berardicurti; Charlotte G Smith; Saba Asam; David H Gardner; Serena Colafrancesco; Davide Lucchesi; Rachel Coleby; Ming-May Chung; Valentina Iannizzotto; Kelly Hunter; Simon J Bowman; Gianluca Carlesso; Ronald Herbst; Helen M McGettrick; Jeff Browning; Christopher D Buckley; Benjamin A Fisher; Michele Bombardieri; Francesca Barone
Journal:  Commun Biol       Date:  2022-05-04

6.  A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression.

Authors:  María de la Luz García-Hernández; Norma Ofelia Uribe-Uribe; Ricardo Espinosa-González; W Martin Kast; Shabaana A Khader; Javier Rangel-Moreno
Journal:  Front Immunol       Date:  2017-05-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.